Study directory

Mental health studies with practical context.

Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.

Back to overview
5650studies shown
Showing 877-888 of 5,650
Biological study icon
RecruitingNCT05934474

Biocollection on Peripheral Inflammation

This observational study is following people with schizoaffective disorder, Depressive Type, bipolarity I, or bipolarity II to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Nantes
Bipolarity, Schizophrenia, ...BiologicalOver 18 Years
Countries
France
Sponsor
Nantes University Hospital
Condition
Bipolarity, Schizophrenia, ...
Drug study icon
RecruitingNCT04421248

Biomarker Validation in Motor System Physiology in Attention Deficit Hyperactivity Disorder

This study is comparing Methylphenidate with placebo for people with Attention Deficit Hyperactivity Disorder Combined. Participants receive Methylphenidate or placebo and complete study visits and assessments.

Multiple locations, including Baltimore
ADHDDrugA study involving a medication or substance.From 8 Years to 12 Years
Countries
United States
Sponsor
Donald Gilbert, MD, MS, FAAN, FAAP
Condition
ADHD
Device study icon
RecruitingNCT04041479

Biomarker-guided rTMS for Treatment Resistant Depression

This study is looking at whether a digital support tool can help people with Treatment Resistant Depression or depression. Participants take part in a digital support tool and complete follow-up assessments.

Multiple locations, including Stanford
DepressionDeviceA study involving a tool, app, wearable, test, or medical device.From 22 Years to 65 Years
Countries
United States
Sponsor
Weill Medical College of Cornell University
Condition
Depression
Behavioral study icon
RecruitingNCT07340281

Biomarkers for Exercise

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand what blood tests and biological markers can reveal about signals in the brain or body that may guide care later on.

In New York
AnxietyBehavioralFrom 18 Years to 50 Years
Countries
United States
Sponsor
NYU Langone Health
Condition
Anxiety
Drug study icon
RecruitingNCT05316883

Biomarkers in Clozapine-responding Schizophrenia

This observational study is following people with Schizophrenia or Psychosis to understand outcomes over time. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Glostrup Municipality
SchizophreniaDrugFrom 18 Years to 64 Years
Countries
Denmark
Sponsor
Jimmi Nielsen
Condition
Schizophrenia
Behavioral study icon
RecruitingNCT04581902

Biomarkers of Depression and Treatment Response

This study is looking at whether rTMS therapy can help people with major depression. Participants take part in rTMS therapy and complete follow-up assessments.

In San Francisco
DepressionBehavioralFrom 18 Years to 70 Years
Countries
United States
Sponsor
University of California, San Francisco
Condition
Depression
Behavioral study icon
RecruitingNCT06221176

Biomarkers Research in Anxiety for Validation and Efficacy

This study exists to see whether cognitive behavioural therapy, a structured talking treatment, is workable and worth testing more broadly. Researchers are trying to understand whether cognitive behavioural therapy, a structured talking treatment, can improve attention, thinking, or day-to-day functioning.

In Brookline
AnxietyBehavioralFrom 3 Years to 6 Years
Countries
United States
Sponsor
Boston Children's Hospital
Condition
Anxiety
Drug study icon
RecruitingNCT06969755

Biomarkers to Enhance Early Schizophrenia Treatment

This study exists to explore whether blood tests and biological markers could improve care and understanding. Researchers are trying to understand whether blood tests and biological markers can give earlier or clearer feedback during care.

Multiple locations, including Birmingham
SchizophreniaDrugFrom 18 Years to 35 Years
Countries
United States, Canada
Sponsor
Northwell Health
Condition
Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.